These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10640985)
1. Adhesion molecule expression in breast cancer: the phoenix in tumour metastasis? Ilyas M J Pathol; 2000 Jan; 190(1):3-5. PubMed ID: 10640985 [TBL] [Abstract][Full Text] [Related]
2. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. Bukholm IK; Nesland JM; Børresen-Dale AL J Pathol; 2000 Jan; 190(1):15-9. PubMed ID: 10640987 [TBL] [Abstract][Full Text] [Related]
3. E-cadherin-catenin cell-cell adhesion complex and human cancer. Wijnhoven BP; Dinjens WN; Pignatelli M Br J Surg; 2000 Aug; 87(8):992-1005. PubMed ID: 10931041 [TBL] [Abstract][Full Text] [Related]
4. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859 [TBL] [Abstract][Full Text] [Related]
5. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. Liu J; Ikeguchi M; Nakamura S; Kaibara N J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532 [TBL] [Abstract][Full Text] [Related]
6. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
8. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863 [TBL] [Abstract][Full Text] [Related]
10. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Yoshida R; Kimura N; Harada Y; Ohuchi N Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480 [TBL] [Abstract][Full Text] [Related]
11. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma. Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858 [TBL] [Abstract][Full Text] [Related]
12. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours. Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137 [TBL] [Abstract][Full Text] [Related]
13. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas. Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268 [TBL] [Abstract][Full Text] [Related]
14. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267 [TBL] [Abstract][Full Text] [Related]
15. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184 [TBL] [Abstract][Full Text] [Related]
16. Exchange of catenins in cadherin-catenin complex. Klingelhöfer J; Troyanovsky RB; Laur OY; Troyanovsky S Oncogene; 2003 Feb; 22(8):1181-8. PubMed ID: 12606944 [TBL] [Abstract][Full Text] [Related]
17. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560 [TBL] [Abstract][Full Text] [Related]
18. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. Nakamura E; Sugihara H; Bamba M; Hattori T J Pathol; 2005 Feb; 205(3):349-58. PubMed ID: 15682444 [TBL] [Abstract][Full Text] [Related]
19. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521 [TBL] [Abstract][Full Text] [Related]